Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.49% | $3.91B | €413.15B | 48.58% | 76 Outperform | |
| AstraZeneca | 0.99% | $2.61B | £220.41B | 29.45% | 80 Outperform | |
| Roche Holding AG | 0.96% | $2.52B | CHF272.24B | 45.48% | 73 Outperform | |
| Nestlé SA | 0.90% | $2.36B | CHF190.59B | 15.67% | 71 Outperform | |
| SAP SE | 0.88% | $2.33B | €241.78B | -14.21% | 66 Neutral | |
| HSBC Holdings | 0.88% | $2.32B | £205.11B | 49.44% | 80 Outperform | |
| Novartis AG | 0.87% | $2.29B | CHF217.04B | 25.19% | 80 Outperform | |
| Royal Bank Of Canada | 0.78% | $2.05B | $236.46B | 43.18% | 75 Outperform | |
| Shell (UK) | 0.77% | $2.03B | £150.06B | 0.57% | 73 Outperform | |
| Toyota Motor | 0.76% | $2.01B | ¥44.16T | 14.07% | 80 Outperform |